Barrett Ablation denied as not FDA-approved for this use by Humana?

Humana's specific coverage criteria for barrett ablation are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Denies Barrett's Esophagus Ablation as Not FDA-Approved — and Why You Can Appeal

Humana's "not FDA-approved" denial for Barrett's esophagus ablation means the plan has determined that the specific device, system, or technique used to perform the ablation lacks FDA marketing authorization, or that the requested use falls outside the cleared or approved indication. For established ablation systems, this denial reason may reflect outdated policy language, incorrect device identification, or application of a coverage standard that does not match the current regulatory status of the technology. For newer or emerging ablation platforms, the denial may be accurate as to regulatory status but still appealable on other grounds. Understanding the exact basis is essential before crafting your appeal.

## Your Federal Appeal Rights

ACA §2719 requires ACA-regulated plans to provide internal appeals and independent external review. ERISA §503 applies to employer plans. You have approximately four months from the denial date to pursue external review. Expedited review is available when standard timelines would jeopardize your health.

## The Appeal Process

1. Request the complete denial explanation. Humana must identify which device or technique it determined lacks FDA approval and cite the policy provision applied. 2. Verify the FDA authorization status of the specific device your provider intends to use. Your provider can supply the FDA 510(k) clearance number or PMA approval documentation for the device. 3. File a Level 1 internal appeal with the FDA authorization documentation attached, along with your physician's medical-necessity letter. 4. Proceed to Level 2 and external review if the internal appeal does not succeed.

## Documentation to Gather

• FDA device authorization documentation: The 510(k) clearance number, PMA approval, or De Novo grant for the specific ablation device your provider will use, obtainable from FDA's public device database or from the device manufacturer.
• Diagnosis confirmation: Endoscopy and pathology records establishing the Barrett's esophagus diagnosis.
• Clinical severity: Current records documenting disease extent and the clinical rationale for ablative treatment.
• Prescriber medical-necessity letter: A letter from your treating physician confirming the specific FDA-cleared or approved device to be used and explaining why it is the appropriate choice for your condition under current clinical practice guidelines.

## Criteria-Mapping Strategy

Obtain Humana's medical policy and identify the specific language on FDA approval or clearance. Then document the regulatory authorization for the exact device your provider intends to use, matching that documentation to the policy language. If the device is FDA-cleared for the specific indication matching your diagnosis, present that match explicitly. If Humana's policy language is outdated relative to the current regulatory status of the technology, note the discrepancy and request that Humana apply its policy based on current FDA authorization records. Professional society guidelines from the American Society for Gastrointestinal Endoscopy or the American College of Gastroenterology can further support the clinical appropriateness of the procedure.